Citation: | CHEN Yilai, CHEN Yudong, ZHAN Weiwei, ZHOU Wei. Relationship between and FNA-Tg and the size of metastatic lymph nodes from papillary thyroid carcinoma[J]. Journal of Molecular Imaging, 2024, 47(3): 237-241. doi: 10.12122/j.issn.1674-4500.2024.03.03 |
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[2] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
|
[3] |
Ito Y, Fukushima M, Tomoda C, et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment[J]. Endocr J, 2009, 56(6): 759-66. doi: 10.1507/endocrj.K09E-025
|
[4] |
Kim DW, Choo HJ, Lee YJ, et al. Sonographic features of cervical lymph nodes after thyroidectomy for papillary thyroid carcinoma [J]. J Ultrasound Med, 2013, 32(7): 1173-80. doi: 10.7863/ultra.32.7.1173
|
[5] |
Wu MH, Shen WT, Gosnell J, et al. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer[J]. Head Neck, 2015, 37(9): 1336-43. doi: 10.1002/hed.23747
|
[6] |
Cracchiolo JR, Wong RJ. Management of the lateral neck in well differentiated thyroid cancer[J]. Eur J Surg Oncol, 2018, 44(3): 332-7. doi: 10.1016/j.ejso.2017.06.004
|
[7] |
Xu YX, Wu DP, Wu WT, et al. Diagnostic value of cytology, thyroglobulin, and combination of them in fine-needle aspiration of metastatic lymph nodes in patients with differentiated thyroid cancer: a systematic review and network meta-analysis[J]. Medicine, 2019, 98(45): e17859. doi: 10.1097/MD.0000000000017859
|
[8] |
Leenhardt L, Erdogan MF, Hegedus L, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer[J]. Eur Thyroid J, 2013, 2(3): 147-59. doi: 10.1159/000354537
|
[9] |
Boi F, Baghino G, Atzeni F, et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-tg antibodies[J]. J Clin Endocrinol Metab, 2006, 91(4): 1364-9. doi: 10.1210/jc.2005-1705
|
[10] |
Zhu XH, Zhou JN, Qian YY, et al. Diagnostic values of thyroglobulin in lymph node fine- needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg [J]. Endocr J, 2020, 67(2): 113-23. doi: 10.1507/endocrj.EJ18-0558
|
[11] |
Grani G, Fumarola A. Thyroglobulin in lymph node fine- needle aspiration washout: a systematic review and meta- analysis of diagnostic accuracy[J]. J Clin Endocrinol Metab, 2014, 99(6): 1970-82. doi: 10.1210/jc.2014-1098
|
[12] |
Zhao H, Wang Y, Wang MJ, et al. Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma[J]. BMC Cancer, 2017, 17(1): 296. doi: 10.1186/s12885-017-3296-3
|
[13] |
Duval MADS, Zanella AB, Cristo AP, et al. Impact of serum TSH and anti-thyroglobulin antibody levels on lymph node fine- needle aspiration thyroglobulin measurements in differentiated thyroid cancer patients[J]. Eur Thyroid J, 2017, 6(6): 292-7. doi: 10.1159/000479682
|
[14] |
Netzel BC, Grebe SKG, Carranza Leon BG, et al. Thyroglobulin (tg) testing revisited: tg assays, TgAb assays, and correlation of results with clinical outcomes[J]. J Clin Endocrinol Metab, 2015, 100(8): E1074-83. doi: 10.1210/jc.2015-1967
|
[15] |
Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013[J]. JAMA, 2017, 317(13): 1338-48. doi: 10.1001/jama.2017.2719
|
[16] |
Gharib H, Papini E, Garber JR, et al. American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: 2016 update[J]. Endocr Pract, 2016, 22(5): 622-39.
|
[17] |
Jeon MJ, Kim WG, Jang EK, et al. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level[J]. Thyroid, 2015, 25(4): 410-6. doi: 10.1089/thy.2014.0544
|
[18] |
Wang JH, Jiang XF, Xiao GZ, et al. Excellent diagnostic performance of FNA-Tg in detecting lymph nodes metastases from papillary thyroid cancer[J]. Future Oncol, 2020, 16(33): 2735-46. doi: 10.2217/fon-2020-0213
|
[19] |
Shin HJ, Lee HS, Kim EK, et al. A study on serum antithyroglobulin antibodies interference in thyroglobulin measurement in fine-needle aspiration for diagnosing lymph node metastasis in postoper-ative patients[J]. PLoS One, 2015, 10(6): e0131096. doi: 10.1371/journal.pone.0131096
|
[20] |
Moon JH, Kim YI, Lim JA, et al. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results[J]. J Clin Endocrinol Metab, 2013, 98(3): 1061-8. doi: 10.1210/jc.2012-3291
|
[21] |
Cappelli C, Pirola I, De Martino E, et al. Thyroglobulin measurement in fine- needle aspiration biopsy of metastatic lymph nodes after rhTSH stimulation[J]. Head Neck, 2013, 35(1): E21-3.
|
[22] |
Giovanella L, Suriano S, Ceriani L, et al. Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan[J]. Clin Nucl Med, 2011, 36(2): 109-12. doi: 10.1097/RLU.0b013e318203bb84
|
[23] |
Chung J, Kim EK, Lim H, et al. Optimal indication of thyroglobulin measurement in fine- needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma [J]. Head Neck, 2014, 36(6): 795-801. doi: 10.1002/hed.23371
|
[24] |
Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension[J]. Thyroid, 2012, 22(11): 1144-52. doi: 10.1089/thy.2012.0043
|
[25] |
Barbosa MP, Momesso D, Bulzico DA, et al. Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer[J]. Arch Endocrinol Metab, 2017, 61(6): 584-9. doi: 10.1590/2359-3997000000307
|
[26] |
Layfield LJ. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis[J]. Diagn Cytopathol, 2007, 35(12): 798-805. doi: 10.1002/dc.20769
|
[27] |
Alpert EH, Wenig BM, Dewey EH, et al. Size distribution of metastatic lymph nodes with extranodal extension in patients with papillary thyroid cancer: a pilot study[J]. Thyroid, 2015, 25(2): 238-41. doi: 10.1089/thy.2014.0392
|
[28] |
Siddiqui S, White MG, Antic T, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma[J]. Thyroid, 2016, 26(6): 807-15. doi: 10.1089/thy.2015.0429
|
[29] |
Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation[J]. Cardiovasc Intervent Radiol, 2016, 39(7): 1023-30. doi: 10.1007/s00270-016-1313-6
|